Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chubb
Fish and Richardson
Daiichi Sankyo
Novartis
Teva
Argus Health
Mallinckrodt
UBS
Harvard Business School
US Department of Justice

Generated: January 17, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 203266

« Back to Dashboard

NDA 203266 describes GEMFIBROZIL, which is a drug marketed by Mylan, Purepac Pharm, Apotex, Aurobindo Pharma Ltd, Cadila Pharms Ltd, Caribe Holdings, Chartwell Molecules, Hikma Pharms, Impax Pharms, Invagen Pharms, Northstar Hlthcare, Sandoz, Sun Pharm Inds Inc, Teva, and Watson Labs, and is included in eighteen NDAs. It is available from fifty-two suppliers. Additional details are available on the GEMFIBROZIL profile page.

The generic ingredient in GEMFIBROZIL is gemfibrozil. Fifty-three suppliers are listed for this compound. Additional details are available on the gemfibrozil profile page.
Summary for 203266
Tradename:GEMFIBROZIL
Applicant:Cadila Pharms Ltd
Ingredient:gemfibrozil
Patents:0
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 203266
Medical Subject Heading (MeSH) Categories for 203266
Suppliers and Packaging for NDA: 203266
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
GEMFIBROZIL gemfibrozil TABLET;ORAL 203266 ANDA Cadila Pharmaceuticals Limited 71209-008 71209-008-10 500 TABLET in 1 BOTTLE (71209-008-10)
GEMFIBROZIL gemfibrozil TABLET;ORAL 203266 ANDA Cadila Pharmaceuticals Limited 71209-008 71209-008-08 180 TABLET in 1 BOTTLE (71209-008-08)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength600MG
Approval Date:Jun 17, 2016TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Dow
Fish and Richardson
AstraZeneca
Mallinckrodt
Deloitte
Boehringer Ingelheim
US Army
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot